Bli medlem
Bli medlem

Du är här


SCA: Invitation to SCA's Q1 2016 press conference

The press conference held in connection with the publication of SCA's
interim report for the first quarter of 2016 will also be available
via webcast and it is possible to join by phone.

The interim report will be published on April 28, 2016 at
approximately 08:00 CET. The subsequent press conference will be held
at 10:00 CET at SCA's headquarters, Waterfront Building,
Klarabergsviadukten 63, Stockholm, Sweden.

At the press conference, President and CEO Magnus Groth will present
and answer questions regarding the report.

Press conference:
Date: Thursday, April 28, 2016
Time: 10:00 CET
Venue: SCA Headquarters, Waterfront Building, Klarabergsviadukten 63,
Stockholm, Sweden

The press conference will be webcast live at It is also
possible to participate in the press conference by telephone by
calling +44 (0)20 7162 0077, +1 334 323 6201, or +46 (0)8 5052 0110.
Call in good time before the conference starts. Provide the code
"SCA" or the conference ID 958264.

For additional information please contact:
Johan Karlsson, Vice President Investor Relations, 46 8 788 51 30
Karl Stoltz, Media Relations Manager, 46 8 788 51 55

SCA is a leading global hygiene and forest products company. The Group
develops and produces sustainable personal care, tissue and forest
products. Sales are conducted in about 100 countries under many
strong brands, including the leading global brands TENA and Tork, and
regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba,
Tempo, Vinda and Zewa. As Europe's largest private forest owner, SCA
places considerable emphasis on sustainable forest management. The
Group has about 44,000 employees. Sales in 2015 amounted to
approximately SEK 115bn (EUR 12.3bn). SCA was founded in 1929, has
its headquarters in Stockholm, Sweden, and is listed on NASDAQ OMX
Stockholm. For more information, visit


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.